Skip to content

A clinical study to evaluate the effects of the test food on attenuating fatigue sensation

A clinical study to evaluate the effects of the test food on attenuating fatigue sensation - A clinical study to evaluate the effects of the test food on attenuating fatigue sensation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000041228
Enrollment
24
Registered
2021-03-01
Start date
2020-08-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Intake of test food for 4 weeks - &gt
Intake of placebo for 4 weeks Intake of placebo for 4 weeks - &gt

Sponsors

Soiken Inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Males and females whose age of 20 years or more and less than 65 years 2) Subjects who perceive fatigue sensation in daily work 3) Subjects receiving a sufficient briefing of the objective and content of the present study, fully understanding and agreeing to voluntarily participate in the study and being able to personally sign a written informed consent

Exclusion criteria

Exclusion criteria: 1) Subjects with serious cardio-vascular, hepatic, renal, respiratory, endocrine or metabolic disorders or having a medical history of these disorders 2) Subjects with chronic fatigue syndrome (CFS), or subjects deemed to have severe fatigue such as idiopathic chronic fatigue by the investigator 3) Subjects who take regularly pharmaceuticals or quasi-drugs which having the efficacy for recovery from fatigue or nutritional supplements during physical fatigue 4) Subjects who take regularly Foods with Function Claims labeled the effect of attenuating fatigue sensation 5) Subjects who have the possibility of developing allergic symptoms by the test food 6) Female subjects who are pregnant or lactating, or intending to become pregnant during the study 7) Subjects having blood sample of 200 ml or more taken within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood) 8) Subjects who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study 9) Subjects deemed unsuitable by the investigator

Design outcomes

Primary

MeasureTime frame
VAS(fatigue sensation)

Secondary

MeasureTime frame
VAS(eyestrain, sleepiness, shoulder stiffness, dullness or heaviness in the body, motivation), Jikaku-sho shirabe, Pittsburgh Sleep Quality Index, OSA sleep inventory MA version, Karolinska Sleepiness Scale, POMS2 Japanese version, work performance evaluation, cognitive function test, autonomic nervous function evaluation, urinalysis

Countries

Japan

Contacts

Public ContactTomohiro Sugino

Soiken Inc. R&D Division

sugino@soiken.com06-6871-8888

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026